Screening of Potential Biomarkers for Gastric Cancer with Diagnostic Value Using Label-free Global Proteome Analysis
- Author:
Song YONGXI
1
;
Wang JUN
;
Sun JINGXU
;
Chen XIAOWAN
;
Shi JINXIN
;
Wu ZHONGHUA
;
Yu DEHAO
;
Zhang FEI
;
Wang ZHENNING
Author Information
1. Department of Surgical Oncology and General Surgery,Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors,Ministry of Education,The First Affiliated Hospital of China Medical University,Shenyang 110001,China
- Keywords:
Gastric cancer;
Proteomics;
Label-free;
Bioinformatics;
Diagnosis
- From:
Genomics, Proteomics & Bioinformatics
2020;18(6):679-695
- CountryChina
- Language:Chinese
-
Abstract:
Gastric cancer (GC) is known as a top malignant type of tumors worldwide. Despite the recent decrease in mortality rates, the prognosis remains poor. Therefore, it is necessary to find novel biomarkers with early diagnostic value for GC. In this study, we present a large-scale proteomic analysis of 30 GC tissues and 30 matched healthy tissues using label-free global proteome profiling. Our results identified 537 differentially expressed proteins, including 280 upregulated and 257 downregulated pro-teins. The ingenuity pathway analysis (IPA) results indicated that the sirtuin signaling pathway was the most activated pathway in GC tissues whereas oxidative phosphorylation was the most inhibited. More-over, the most activated molecular function was cellular movement, including tissue invasion by tumor cell lines. Based on IPA results, 15 hub proteins were screened. Using the receiver operating character-istic curve, most of hub proteins showed a high diagnostic power in distinguishing between tumors and healthy controls. A four-protein (ATP5B-ATP5O-NDUFB4-NDUFB8) diagnostic signature was built using a random forest model. The area under the curve (AUC) values of this model were 0.996 and 0.886 for the training and testing sets, respectively, suggesting that the four-protein signature has a high diag-nostic power. This signature was further tested with independent datasets using plasma enzyme-linked immune sorbent assays, resulting in an AUC value of 0.778 for distinguishing GC tissues from healthy controls, and using immunohistochemical tissue microarray analysis, resulting in an AUC value of 0.805. In conclusion, this study identifies potential biomarkers and improves our understanding of the pathogenesis, providing novel therapeutic targets for GC.
